A large Swedish trial finds that AI-assisted mammography detects more breast cancers and reduces future diagnosis rates compared to standard practices.
Key Details
- 1MASAI trial included more than 105,000 women in Sweden between 2021-2022.
- 2AI-supported mammography led to a 12% reduction in subsequent breast cancer diagnoses.
- 3Trial compared AI triage/detection to the standard two-radiologist double reading.
- 4AI was developed/trained on over 200,000 exams from more than 10 countries.
- 5Implementation should be cautious, with monitoring and validated AI tools.
- 6Published in The Lancet; lead author is Dr. Kristina Lång from Lund University.
Why It Matters
This is one of the first randomized controlled trials providing robust evidence that AI can enhance breast cancer screening programs, potentially improving early detection and reducing radiologist workload. These findings could accelerate responsible clinical adoption of AI in mammography.
Source
Radiology Business
Related News
•AuntMinnie
AI-Based Slab Reconstruction Streamlines Digital Breast Tomosynthesis
AI-driven slab reconstruction in DBT improves workflow efficiency without compromising diagnostic accuracy in breast cancer screening.
•AuntMinnie
AI Advances in Breast Cancer Risk, CEUS Training Updates, and Imaging AI Variability
This week's top radiology news reviews AI advances in breast and lung cancer risk prediction, new CEUS training standards, and prostate screening updates with imaging modalities.
•AuntMinnie
Mammography AI Model Outperforms Rivals for 10-Year Breast Cancer Risk
A new mammography-based AI model predicts 10-year breast cancer risk more accurately than established clinical and AI models.